164 related articles for article (PubMed ID: 30867471)
1. Prognostic Impact of Carboxylesterase 2 in Cholangiocarcinoma.
Goeppert B; Renner M; Singer S; Albrecht T; Zhang Q; Mehrabi A; Pathil A; Springfeld C; Köhler B; Rupp C; Weiss KH; Kühl AA; Arsenic R; Pape UF; Vogel A; Schirmacher P; Roessler S; Utku N
Sci Rep; 2019 Mar; 9(1):4338. PubMed ID: 30867471
[TBL] [Abstract][Full Text] [Related]
2. An S100P-positive biliary epithelial field is a preinvasive intraepithelial neoplasm in nodular-sclerosing cholangiocarcinoma.
Nakanuma Y; Uchida T; Sato Y; Uesaka K
Hum Pathol; 2017 Feb; 60():46-57. PubMed ID: 27984121
[TBL] [Abstract][Full Text] [Related]
3. Role of CD15 expression in dysplastic and neoplastic tissue of the bile duct - a potential novel tool for differential diagnosis of indeterminate biliary stricture.
Walter D; Herrmann E; Winkelmann R; Albert JG; Liese J; Schnitzbauer A; Zeuzem S; Hansmann ML; Peveling-Oberhag J; Hartmann S
Histopathology; 2016 Dec; 69(6):962-970. PubMed ID: 27442966
[TBL] [Abstract][Full Text] [Related]
4. The Prognostic Role of SOCS3 and A20 in Human Cholangiocarcinoma.
Wang Y; Wan M; Zhou Q; Wang H; Wang Z; Zhong X; Zhang L; Tai S; Cui Y
PLoS One; 2015; 10(10):e0141165. PubMed ID: 26485275
[TBL] [Abstract][Full Text] [Related]
5. TTF-1 and Napsin-A are expressed in a subset of cholangiocarcinomas arising from the gallbladder and hepatic ducts: continued caveats for utilization of immunohistochemistry panels.
Surrey LF; Frank R; Zhang PJ; Furth EE
Am J Surg Pathol; 2014 Feb; 38(2):224-7. PubMed ID: 24418856
[TBL] [Abstract][Full Text] [Related]
6. Aberrant expression of B7-H4 correlates with poor prognosis and suppresses tumor-infiltration of CD8+ T lymphocytes in human cholangiocarcinoma.
Zhao X; Guo F; Li Z; Jiang P; Deng X; Tian F; Li X; Wang S
Oncol Rep; 2016 Jul; 36(1):419-27. PubMed ID: 27177355
[TBL] [Abstract][Full Text] [Related]
7. The expression of gastrointestinal differentiation markers in extrahepatic cholangiocarcinoma: clinicopathological significance based on tumor location.
Ishida K; Osakabe M; Eizuka M; Tai S; Sugimoto R; Fujita Y; Katagiri H; Takahara T; Uesugi N; Nitta H; Sasaki A; Sugai T
Hum Pathol; 2019 Oct; 92():91-100. PubMed ID: 31401234
[TBL] [Abstract][Full Text] [Related]
8. YKL-40/chitinase-3-like protein 1 is associated with poor prognosis and promotes cell growth and migration of cholangiocarcinoma.
Thongsom S; Chaocharoen W; Silsirivanit A; Wongkham S; Sripa B; Choe H; Suginta W; Talabnin C
Tumour Biol; 2016 Jul; 37(7):9451-63. PubMed ID: 26781979
[TBL] [Abstract][Full Text] [Related]
9. Carboxylesterase 2 as a Determinant of Response to Irinotecan and Neoadjuvant FOLFIRINOX Therapy in Pancreatic Ductal Adenocarcinoma.
Capello M; Lee M; Wang H; Babel I; Katz MH; Fleming JB; Maitra A; Wang H; Tian W; Taguchi A; Hanash SM
J Natl Cancer Inst; 2015 Aug; 107(8):. PubMed ID: 26025324
[TBL] [Abstract][Full Text] [Related]
10. Opposing Roles of FoxA1 and FoxA3 in Intrahepatic Cholangiocarcinoma Progression.
Thanan R; Kaewlert W; Sakonsinsiri C; Chaiprasert T; Armartmuntree N; Muengsaen D; Techasen A; Klanrit P; Lert-Itthiporn W; Pinlaor S; Pairojkul C
Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32151057
[TBL] [Abstract][Full Text] [Related]
11. Human carboxylesterase 2 is commonly expressed in tumor tissue and is correlated with activation of irinotecan.
Xu G; Zhang W; Ma MK; McLeod HL
Clin Cancer Res; 2002 Aug; 8(8):2605-11. PubMed ID: 12171891
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of lactate dehydrogenase A in cholangiocarcinoma is correlated with poor prognosis.
Thonsri U; Seubwai W; Waraasawapati S; Sawanyawisuth K; Vaeteewoottacharn K; Boonmars T; Cha'on U
Histol Histopathol; 2017 May; 32(5):503-510. PubMed ID: 27615379
[TBL] [Abstract][Full Text] [Related]
13. STATs profiling reveals predominantly-activated STAT3 in cholangiocarcinoma genesis and progression.
Dokduang H; Techasen A; Namwat N; Khuntikeo N; Pairojkul C; Murakami Y; Loilome W; Yongvanit P
J Hepatobiliary Pancreat Sci; 2014 Oct; 21(10):767-76. PubMed ID: 25044480
[TBL] [Abstract][Full Text] [Related]
14. The prognostic role of lymphovascular invasion and lymph node metastasis in perihilar and intrahepatic cholangiocarcinoma.
Lurje G; Bednarsch J; Czigany Z; Lurje I; Schlebusch IK; Boecker J; Meister FA; Tacke F; Roderburg C; Den Dulk M; Gaisa NT; Bruners P; Neumann UP
Eur J Surg Oncol; 2019 Aug; 45(8):1468-1478. PubMed ID: 31053477
[TBL] [Abstract][Full Text] [Related]
15. lnc-PKD2-2-3, identified by long non-coding RNA expression profiling, is associated with pejorative tumor features and poor prognosis, enhances cancer stemness and may serve as cancer stem-cell marker in cholangiocarcinoma.
Qiu G; Ma D; Li F; Sun D; Zeng Z
Int J Oncol; 2019 Jul; 55(1):45-58. PubMed ID: 31059014
[TBL] [Abstract][Full Text] [Related]
16. Overexpressed CES2 has prognostic value in CRC and knockdown CES2 reverses L-OHP-resistance in CRC cells by inhibition of the PI3K signaling pathway.
Zhang Y; Sun L; Sun Y; Chen Y; Wang X; Xu M; Chi P; Xu Z; Lu X
Exp Cell Res; 2020 Apr; 389(1):111856. PubMed ID: 31981591
[TBL] [Abstract][Full Text] [Related]
17. Aberrant expression of GATA binding protein 6 correlates with poor prognosis and promotes metastasis in cholangiocarcinoma.
Tian F; Li D; Chen J; Liu W; Cai L; Li J; Jiang P; Liu Z; Zhao X; Guo F; Li X; Wang S
Eur J Cancer; 2013 May; 49(7):1771-80. PubMed ID: 23313142
[TBL] [Abstract][Full Text] [Related]
18. PD-L1 expression in extrahepatic cholangiocarcinoma.
Walter D; Herrmann E; Schnitzbauer AA; Zeuzem S; Hansmann ML; Peveling-Oberhag J; Hartmann S
Histopathology; 2017 Sep; 71(3):383-392. PubMed ID: 28419539
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of FXR or TGR5 activation in cholangiocarcinoma progression.
Erice O; Labiano I; Arbelaiz A; Santos-Laso A; Munoz-Garrido P; Jimenez-Agüero R; Olaizola P; Caro-Maldonado A; Martín-Martín N; Carracedo A; Lozano E; Marin JJ; O'Rourke CJ; Andersen JB; Llop J; Gómez-Vallejo V; Padro D; Martin A; Marzioni M; Adorini L; Trauner M; Bujanda L; Perugorria MJ; Banales JM
Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1335-1344. PubMed ID: 28916388
[TBL] [Abstract][Full Text] [Related]
20. MET‑RON dual inhibitor, BMS‑777607, suppresses cholangiocarcinoma cell growth, and MET‑RON upregulation indicates worse prognosis for intra‑hepatic cholangiocarcinoma patients.
Cheng CT; Chen YY; Wu RC; Tsai CY; Chiang KC; Yeh TS; Chen MH; Yeh CN
Oncol Rep; 2018 Sep; 40(3):1411-1421. PubMed ID: 30015968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
